PLEASE TELL US A LITTLE ABOUT YOURSELF SO THAT WE CAN DISPLAY THE MOST
APPROPRIATE CONTENT TO YOU:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies used on Trustnet and how you can manage them, see our Privacy and Cookie Policy.

By clicking "I Agree" below, you acknowledge that you accept our Privacy Policy and Terms of Use.

For more information Click here

Login

Password Reminder
Not Registered? Click Here

Register

Register
It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
You are here: Manager factsheet

Deane Donnigan
Polar Capital
pdfIcon Manager factsheet pdf    rss feed RSS Feed
Manager profile
Deane joined Polar Capital in June 2013 as a senior analyst for the Healthcare team, and has over 38 years’ industry experience, including over 15 years within healthcare asset management. She trained as a clinical pharmacist, graduating with a post baccalaureate Doctor of Pharmacy from the University of Georgia. Deane began her career at the Medical College of Georgia, before becoming a clinical specialist in Drug Information and Adult Internal Medicine with Emory University Hospital in Atlanta, Georgia. After several years, she moved to the UK to join Framlington (now AXA Framlington) as an analyst for the healthcare unit trust, led by Anthony Milford. She went on to become lead portfolio manager of the Framlington Healthcare and Framlington Biotechnology funds. Deane is both a US and UK citizen.
Total return for Deane Donnigan
Manager career performance
Discrete calendar year performance : Deane Donnigan

Manager career performance
Discrete performance
  0-12m 12-24m 24-36m 36-48m 48-60m 60-72m 72-84m 84-96m 96-108m 108-120m
Deane Donnigan 11.6 -7.5 -1.8 56.2 - - - - - -
Peer Group Composite 6.3 -0.7 -1.4 27.8 - - - - - -
Over / Under 5.3 -6.8 -0.4 28.4 - - - - - -
Performance vs peer group composite: Deane Donnigan
How a manager matches up against their peers gives you some idea of how talented they are. Very few managers perform equally well in rising and falling markets, so knowing which type of market a manager is capable of performing well within is also important.
 
Overall markets
Up
Outperformed peer group composite
2 years
out of a possible 4
 
Overall markets
Up
Underperformed peer group composite
2 years
out of a possible 4
 
Rising markets
UpDown
Outperformed peer group composite
2 years
out of a possible 2
 
Falling markets
UpDown
Outperformed peer group composite
0 years
out of a possible 2
Funds currently managed
Fund Sole/Co-managed Sector Periods
Polar Capital Healthcare Discovery Lead manager FO Equity - Pharma Health & Biotech since Jan 31 2020 to present
Funds managed previously
Fund Periods
AXA Framlington Health since Oct 01 1997 to Jun 29 2011
Framlington Intl Port Health since Aug 03 1998 to fund close
AXA Framlington Biotech since Jun 18 2010 to Feb 28 2011
AXA Framlington Biotech since Sep 01 2007 to Mar 31 2008
News & Research: Related articles sector Sector fund Fund group Group manager Manager
Group Bubble trouble, the case for infrastructure and Polar Capital on healthcare: Thoughts from Fundswire this week By Diana Llewellyn  12-Apr-2024
Group The most consistent technology, healthcare and financial funds of the decade By Matteo Anelli  12-Apr-2024
Group Canaccord’s four unloved areas full of opportunities By Jean-Baptiste Andrieux  08-Apr-2024
Group The best and worst funds of Q1 2024 By Gary Jackson  04-Apr-2024
Group Revealed: The nominees for the Alpha Manager of the Year Awards 2024 By Emma Wallis  28-Mar-2024
Group AJ Bell’s six ISA funds for investors of all risk tolerances By Jonathan Jones  27-Mar-2024
Group Too many managers are worried about career risk, says IBOSS’ Metcalfe By Jonathan Jones  27-Mar-2024
Group The fund managers investing in each other By Emma Wallis  26-Mar-2024
Group This couple left £60,000 in cash for three years: Here’s how they should invest it By Emma Wallis  26-Mar-2024
Group The funds and trusts with the highest weightings to Nvidia By Emma Wallis  26-Feb-2024
Group The experts’ perfect fund pairings for global investing By Jean-Baptiste Andrieux  26-Feb-2024
Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

LATEST :

Five reasons to keep hold of your defensive funds

13:00 | Monday, January 20, 2014

Close

You are currently using an old browser which will not be supported by Trustnet after 31/07/2016. To ensure you benefit from all features on the site, please update your browser.   Close

© Trustnet Limited 2024. All Rights Reserved.
Please read our Terms of Use / Disclaimer and Privacy and Cookie Policy.
Data supplied in conjunction with Refinitiv and London Stock Exchange Plc